Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Is Bevacizumab Effective In Inhibiting The Growth Of Recurrent Pterygium?, Sharon L. De La Cruz
Is Bevacizumab Effective In Inhibiting The Growth Of Recurrent Pterygium?, Sharon L. De La Cruz
PCOM Physician Assistant Studies Student Scholarship
Objective: The objective of this selective EBM review is to determine whether or not Bevacizumab is an effective treatment in inhibiting the growth of recurrent pterygium.
Study Design: Review of three published, English language randomized controlled trials published in 2010, 2012, and 2013.
Data Sources: Three randomized controlled trials measuring the efficacy of Bevacizumab to inhibit the growth of recurrent pterygium were found using PubMed and OVID databases.
Outcome(s) Measured: The severity and progression of pterygium recurrence as well as corneal neovascularization were the main outcomes measured. Conjunctival injection, thickness, and size of the fibrovascular tissue were examined in subjects …
In Adult Patients With Diabetic Macular Edema Are Intravetrial Bevacizumab Injections More Effective Than Laser Therapy At Improving Best-Corrected Visual Acuity?, Heather Bladek
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not in adult patients with diabetic macular edema intravetrial bevacizumab injections are more effective than laser therapy at improving best-corrected visual acuity.
STUDY DESIGN: Review of three English language non-blinded randomized control trials from 2010 and 2012.
DATA SOURCES: Non-blinded randomized control trials comparing intravetrial bevacizumab injections to macular laser therapy found using Pubmed and EBSCOhost web databases. All articles were published in peer-reviewed journals.
OUTCOMES MEASURED: The primary outcome of best-corrected visual acuity (BCVA) was measured using the Early Treatment of Diabetic …
Is Bevacizumab (Avastin) Safe And Effective As Adjuvant Chemotherapy For Adult Patients With Stage Iiib Or Iv Non-Small Cell Lung Carcinoma (Nsclc)?, Ashley R. De Kleine
Is Bevacizumab (Avastin) Safe And Effective As Adjuvant Chemotherapy For Adult Patients With Stage Iiib Or Iv Non-Small Cell Lung Carcinoma (Nsclc)?, Ashley R. De Kleine
PCOM Physician Assistant Studies Student Scholarship
OBJECTIVE: The objective of this selective EBM review is to determine whether or not bevacizumab (avastin) is safe and effective as adjuvant chemotherapy for adult patients with stage IIIb or IV non-small cell lung carcinoma (NSCLC).
STUDY DESIGN: Review of three randomized controlled trials (RCT) published in 2006, 2009, and 2011, all English language.
DATA SOURCES: Two randomized, double-blind, controlled clinical trials comparing bevacizumab to placebo as adjunctive chemotherapy, and one RCT comparing bevacizumab as adjunctive chemotherapy versus the use of no adjunctive chemotherapy. All articles were found using PubMed, Medline, and OVID.
OUTCOMES MEASURED: Overall …